2026 Global: Acute External Ventricular Drain-Competitive Review (2032) report
Description
The 2026 Global: Acute External Ventricular Drain-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for acute external ventricular drain by geography and historical trend. The scope of the report extends to sizing of the acute external ventricular drain market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Integra LifeSciences, B. Braun Melsungen, Smiths Medical, Boston Scientific, Natus, Fuji Systems, Spiegelberg, Sophysa, and Neuromedex are among the ten major companies active in the acute external ventricular drain (EVD) market. Medtronic is a global leader offering antimicrobial EVD solutions such as Codman Bactiseal and integrated intracranial pressure monitoring systems that position it at the forefront of infection prevention and neurosurgical drainage technology. Integra LifeSciences supplies a broad neurosurgical portfolio including EVD catheters and drainage systems used in trauma and hydrocephalus care, with extensive clinical adoption across neurocritical units. B. Braun Melsungen, through its Aesculap and critical care divisions, provides sterile drainage devices and supportive disposables for neuro-ICUs and has been consistently listed among leading EVD vendors in market reports. Smiths Medical contributes established catheter and drainage line products for cerebrospinal fluid management, supported by hospital procurement channels and group purchasing agreements. Boston Scientific, while better known for other device families, has expanded its presence in neurosurgical and critical care markets through targeted acquisitions and innovation, increasing its relevance in advanced EVD and monitoring workflows. Natus develops neurodiagnostic and neuromonitoring products that complement EVD usage in acute brain injury and intensive care, strengthening integrated monitoring and drainage strategies in clinical practice. Fuji Systems produces EVD catheters and related cranial drainage equipment with a notable presence in Asia-Pacific and global markets, cited repeatedly in industry analyses of top EVD manufacturers. Spiegelberg GmbH, a specialist in intracranial pressure and cerebrospinal fluid management, supplies precision pressure transducers and drainage systems favored in European neurocritical care settings and appears consistently among leading EVD-focused firms. Sophysa offers modular cerebrospinal fluid management devices and valves used in acute and chronic settings, emphasizing safety features and regulatory approvals across multiple regions. Neuromedex provides neurosurgical disposables and drainage devices, often highlighted in regional market reports for its catheter products and partnerships with hospitals in Europe and Asia. Collectively, these ten companies drive product development toward antimicrobial coatings, integrated ICP monitoring, and user-friendly drainage control to reduce catheter-associated infections and improve cerebrospinal fluid management, trends underscored across recent market research. Regional strengths vary: Medtronic and U.S.-based firms lead in North America while Fuji Systems, Spiegelberg, and Neuromedex strengthen presence in Europe and Asia, reflecting market fragmentation by geography, regulatory approvals, and hospital purchasing practices documented in industry analyses.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for acute external ventricular drain by geography and historical trend. The scope of the report extends to sizing of the acute external ventricular drain market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Integra LifeSciences, B. Braun Melsungen, Smiths Medical, Boston Scientific, Natus, Fuji Systems, Spiegelberg, Sophysa, and Neuromedex are among the ten major companies active in the acute external ventricular drain (EVD) market. Medtronic is a global leader offering antimicrobial EVD solutions such as Codman Bactiseal and integrated intracranial pressure monitoring systems that position it at the forefront of infection prevention and neurosurgical drainage technology. Integra LifeSciences supplies a broad neurosurgical portfolio including EVD catheters and drainage systems used in trauma and hydrocephalus care, with extensive clinical adoption across neurocritical units. B. Braun Melsungen, through its Aesculap and critical care divisions, provides sterile drainage devices and supportive disposables for neuro-ICUs and has been consistently listed among leading EVD vendors in market reports. Smiths Medical contributes established catheter and drainage line products for cerebrospinal fluid management, supported by hospital procurement channels and group purchasing agreements. Boston Scientific, while better known for other device families, has expanded its presence in neurosurgical and critical care markets through targeted acquisitions and innovation, increasing its relevance in advanced EVD and monitoring workflows. Natus develops neurodiagnostic and neuromonitoring products that complement EVD usage in acute brain injury and intensive care, strengthening integrated monitoring and drainage strategies in clinical practice. Fuji Systems produces EVD catheters and related cranial drainage equipment with a notable presence in Asia-Pacific and global markets, cited repeatedly in industry analyses of top EVD manufacturers. Spiegelberg GmbH, a specialist in intracranial pressure and cerebrospinal fluid management, supplies precision pressure transducers and drainage systems favored in European neurocritical care settings and appears consistently among leading EVD-focused firms. Sophysa offers modular cerebrospinal fluid management devices and valves used in acute and chronic settings, emphasizing safety features and regulatory approvals across multiple regions. Neuromedex provides neurosurgical disposables and drainage devices, often highlighted in regional market reports for its catheter products and partnerships with hospitals in Europe and Asia. Collectively, these ten companies drive product development toward antimicrobial coatings, integrated ICP monitoring, and user-friendly drainage control to reduce catheter-associated infections and improve cerebrospinal fluid management, trends underscored across recent market research. Regional strengths vary: Medtronic and U.S.-based firms lead in North America while Fuji Systems, Spiegelberg, and Neuromedex strengthen presence in Europe and Asia, reflecting market fragmentation by geography, regulatory approvals, and hospital purchasing practices documented in industry analyses.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.